🟢 Lantern Pharma is trading 7.8% up in pre-market amid announced offering targeting about $4 million

Lantern Pharma is trading 7.77% up at $1.17 in pre-market on September 30; the offering is the clearest company-specific context, but no direct link was stated.

• The September 29 registered direct offering targets approximately $4 million gross: 3,669,725 shares or pre-funded warrants at $1.09 each, plus warrants for up to the same number of additional shares. Closing is expected around September 30.
• The price rebounded from the September 29 close of $1.08 after declines of 10.66% on September 28 and 12.95% on September 24; no separate overnight announcement was identified.